Ionis Pharmaceuticals unveiled results from a survey conducted by The Harris Poll showing that 91% of surveyed adults living ...

A new policy from the NIH in the US will cut billions of dollars of funding for research organisations and hospitals outside ...

There’s a new biotech on the scene after MoonLake Immunotherapeutics launched on a mission to develop sonelokimab, a potential inflammatory diseases drug in-licensed from Germany’s Merck KGaA.

As of 2:58:31 PM EDT. Market Open.